Tobacco abuse relates to significantly reduced survival of patients with oropharyngeal carcinomas

European Journal of Cancer Prevention

Volumn 18, Issue 2, 2009, Pages 120-126

  Hilgert, Eva ^a,e,f   Bergmann, Christoph ^a,f   Fichtner, Alexander ^a   Gires, Olivier ^b,c   Issing, Wolfgang ^d  

^a Department of Otorhinolaryngology ^*  (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d FREEMAN HOSPITAL   (United Kingdom)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Alcohol abuse; Head and neck carcinoma; Smoking

Indexed keywords

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; PRIORITY JOURNAL; PROGNOSIS; TOBACCO DEPENDENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; CARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; RETROSPECTIVE STUDIES; SMOKING; SURVIVAL ANALYSIS; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 61449244794     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32831012a4     Document Type: Article

References (22)

1. Baser S, Shannon VR, Eapen GA, Jimenez CA, Onn A, Lin E, Morice RC (2006). Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status. Chest 130:1784-1790.
2. Bier H (1993). Chemotherapeutic drug resistance in the management of head and neck cancer. Eur Arch Otorhinolaryngol 250:200-208.
3. Bloching M, Bootz F, Burkert S (2004). HNO-relevant changes in the current TNM-classification of malignant tumours. HWO 52:497-502.
4. Braakhuis BJ, Tabor MP, Leemans CR, Van Der Waal I, Snow GB, Brakenhoff RH (2002). Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 24:198-206.
5. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP (2005). Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114:806-816.
6. Cloos J, Leemans CR, Van Der Sterre ML, Kuik DJ, Snow GB, Braakhuis BJ (2000). Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 9:713-717.
7. Day GL, Blot WJ, Shore RE, McLaughlin JK, Austin DF, Greenberg RS, et al. (1994). Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst 86:131-137.
8. Dulguerov P, Jacobsen MS, Allai AS, Lehmann W, Calcaterra T (2001). Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 92:3012-3029.
9. Ferrier MB, Spuesens EB, Le Cessie S, Baatenburg De Jong RJ (2005). Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Arch Otolaryngol Head Neck Surg 131:27-32.
10. Homann N, Tillonen J, Meurman JH, Rintamaki H, Lindqvist C, Rautio M, et al. (2000). Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity cancer. Carcinogenesis 21:663-668.
11. Hussey DH, Latourerte HB, Panje WR (1991). Head and neck cancer: an analysis of the incidence, patterns of treatment, and survival at the University of Iowa. Ann Otol Rhinol Laryngol Suppl 152:2-16.
12. Johnson N (2001). Tobacco use and oral cancer: a global perspective. J Dent Educ 65:328-339.
13. La Vecchia C (2007). Alcohol and liver cancer. Eur J Cancer Prev 16:495-497.
14. La Vecchia C, Tavani A. (2007). Coffee and cancer risk: an update. Eur J Cancer Prev 16:385-389.
15. Lopez-Abente G, Munoz-Tinoco C (2005). Time trends in the impact factor of Public Health journals. BMC Public Health 5:24.
16. Pugliano FA, Piccirillo JF, Zequeira MR, Emami B, Perez CA, Simpson JR, Fredrickson JM (1997). Clinical-severity staging system for oropharyngeal cancer: five-year survival rates. Arch Otolaryngol Head Neck Surg 123:1118-1124.
17. Sesterhenn AM, Teymoortash A, Folz BJ, Werner JA (2005). Head and neck cancer in the elderly: a cohort study In 40 patients. Acta Oncol 44: 59-64.
18. Shields PG (2000). Epidemiology of tobacco carcinogenesis. Curr Oncol Rep 2:257-262.
19. Slaughter DP, Southwick HW, Smejkal W (1953). Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6:963-968.
20. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Van Der Wal JE, Snow QB, Leemans CR, Braakhuis BJ (2002). Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 161: 1051-1060.
21. Tsao AS, Liu D, Lee JJ, Spitz M, Hong WK (2006). Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer 106:2428-2436.
22. Warren S, Gates O (1932). Multiple primary malignant tumours. A survey of literature and a statistical study. Am J Cancer 16:1358-1414.